LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.61 | 770.25 | 2176 | 5813 | 0.3743 | 0.4278 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 45.61 | 770.25 | 2324 | 5813 | 0.3998 | 0.4604 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.83 | 770.25 | 2423 | 6223 | 0.3893 | 0.4626 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.83 | 770.25 | 2367 | 6223 | 0.3803 | 0.4513 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 47.83 | 770.25 | 2537 | 6223 | 0.4077 | 0.4851 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.05 | 770.25 | 2605 | 6629 | 0.3929 | 0.4805 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.05 | 770.25 | 2492 | 6629 | 0.3759 | 0.4595 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 50.05 | 770.25 | 2827 | 6629 | 0.4264 | 0.5200 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.27 | 770.25 | 2797 | 7058 | 0.3962 | 0.4971 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.27 | 770.25 | 2733 | 7058 | 0.3872 | 0.4863 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 52.27 | 770.25 | 3087 | 7058 | 0.4373 | 0.5440 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.49 | 770.25 | 3037 | 7555 | 0.4020 | 0.5166 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.49 | 770.25 | 2919 | 7555 | 0.3863 | 0.4985 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 54.49 | 770.25 | 3314 | 7555 | 0.4386 | 0.5573 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.71 | 770.25 | 3232 | 8001 | 0.4039 | 0.5291 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.71 | 770.25 | 3168 | 8001 | 0.3959 | 0.5201 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 56.71 | 770.25 | 3510 | 8001 | 0.4387 | 0.5669 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.94 | 770.25 | 3467 | 8444 | 0.4106 | 0.5457 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.94 | 770.25 | 3357 | 8444 | 0.3975 | 0.5313 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.94 | 770.25 | 3789 | 8444 | 0.4487 | 0.5859 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.16 | 770.25 | 3765 | 8892 | 0.4234 | 0.5677 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.16 | 770.25 | 3482 | 8892 | 0.3916 | 0.5334 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 61.16 | 770.25 | 4041 | 8892 | 0.4545 | 0.5995 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.39 | 770.25 | 4005 | 9326 | 0.4294 | 0.5812 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.39 | 770.25 | 3833 | 9326 | 0.4110 | 0.5621 | MN20160304_L02 | J05 |